Research

Cigarette butts
First Opinion

Quitting smoking is hard. Mindfulness hacks the habit loop, offering a new approach

By Jud Brewer

Enterovirus D-68
Health

New evidence points to possible cause of puzzling paralysis in kids

By Maggie Fox

Mark Pocan
Politics

House votes to overturn Trump administration ban on fetal tissue research

By Lev Facher and Megan Thielking

Copiers
Pharmalot

How a mishap at a photocopier derailed clinical trials and a development deal

By Ed Silverman

Facebook on phone
In the Lab

Researchers recruit more than 20,000 people for Facebook-based genomics project

By Shraddha Chakradhar

Jennifer Doudna - Genome Editing Conference
Exclusive

GSK partners with CRISPR pioneer Doudna to search for new drugs

By Matthew Herper

Intermountain Medical Center main campus
Business

Intermountain, Amgen subsidiary to launch DNA study of 500,000 patients

By Andrew Joseph

Blood pressure check
Health

Patients whose blood pressure only spikes at the doctor’s office are twice as likely to die of a heart attack or other cardiac event

By Ruth Hailu

TV set
Health

Sleeping with the TV on may make you gain weight

By Associated Press

Health

Scientists feel chill of crackdown on fetal tissue research

By Associated Press

Immunotherapies NIH lab
Opinions Plus

Biomarkers provide a bridge to the next frontier in immuno-oncology

By Grey Wilkinson

Healthy lung tissue
Health

Redefining normal: Study shows mutations even in healthy tissues throughout the body

By Brittany Flaherty

Scytonema hofmanni bacteria
In the Lab

‘Jumping genes’ could help CRISPR replace disease-causing DNA, study finds

By Sharon Begley

Al Sandrock Biogen
Exclusive

One of the world’s best drug hunters went after Alzheimer’s. Here’s how he lost

By Matthew Herper

NIH Headquarters
Politics

The Trump administration will end fetal tissue research by government scientists

By Damian Garde

Chuck Grassley, Ron Wyden
Politics

NIH has referred 16 allegations of foreign influence on U.S. research to investigators

By Andrew Joseph

Pharmalot

Pharmalittle: Bristol sets new management team; Pfizer didn’t say drug may reduce Alzheimer’s risk

By Ed Silverman

Ketogenic diet
Health Tech

After two years, diabetes patients see gains with startup’s digital coaching — and some drop-off

By Rebecca Robbins

electronic med records
Opinions Plus

How to apply real-world evidence to outsmart cancer

By Christopher Boone and Viraj Narayanan

National Acadmies of Sciences
In the Lab

National Academy of Sciences approves a new way to expel harassers

By Megan Thielking

DNA tech connection
Biotech

Tempus, a well-funded company run by a Groupon billionaire, wants to get patients into clinical trials

By Matthew Herper

Rainbow of bacteria
Pharma

Your gut microbiome could change the way you metabolize medicines, a new paper says

By Kate Sheridan

China Gene Edited Babies
In the Lab

He Jiankui tried to protect ‘CRISPR babies’ against HIV. But his attempted fix shortens lives, study shows

By Sharon Begley

Affordable Care Act - insurance sign up
Health

The Affordable Care Act erased a racial disparity in cancer care, a new study says

By Matthew Herper

Play
The Readout LOUD

Listen: Feuding professors, failing businesses, and journalism 101

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Male and female symbols
In the Lab

Seeking reform, a neuroscientist argues against ‘sexist’ beliefs that keep research focused on male animals

By Shraddha Chakradhar

Cancer Financial Toxicity
Pharmalot

More new cancer therapies are being launched than ever before, but spending is skyrocketing

By Ed Silverman

Green and purple bacteria
Biotech

A wave of NIH-backed microbiome research examines the gut’s link to diabetes, inflammatory bowel disease, and more

By Kate Sheridan

Pharmalot

Pharmalittle: Purdue affiliate swept up in Italian probe; new studies question FDA approval methods

By Ed Silverman

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy